As of 2025-12-30, the EV/EBITDA ratio of Codiak BioSciences, Inc. (CDAK) is 0.34. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. CDAK's latest enterprise value is -21.30 mil USD. CDAK's TTM EBITDA according to its financial statements is -62.43 mil USD. Dividing these 2 quantities gives us the above CDAK EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 15.5x - 20.4x | 16.9x |
| Forward P/E multiples | 14.5x - 24.9x | 19.0x |
| Fair Price | (11.22) - (14.91) | (13.08) |
| Upside | -19789.3% - -26255.3% | -23048.5% |
| Date | EV/EBITDA |